NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 260-268

  Zhou, Hongfei ^a   Dehn, Donna ^a   Kepa, Jadwiga K ^a   Siegel, David ^a   Scott, Devon E ^b   Tan, Wei ^b   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXY 1,2 DIMETHYL 3 [(4 NITROPHENOXY)METHYL]INDOLE 4,7 DIONE; ACTIVATING TRANSCRIPTION FACTOR 2; CD3 ANTIGEN; CD34 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENZYME INHIBITOR; ES 936; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE QUINONE OXIDOREDUCTASE 1; PROTEIN C JUN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL TYPE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, CD34; BONE MARROW CELLS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TRANSFORMED; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOBLOTTING; INDOLEQUINONES; INTERCELLULAR ADHESION MOLECULE-1; NAD(P)H DEHYDROGENASE (QUINONE); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77953778885     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.167841     Document Type: Article

References (42)

1. Ahn KS, Sethi G, Jain AK, Jaiswal AK, and Aggarwal BB (2006) Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogenactivated protein kinases and potentiates apoptosis. J Biol Chem 281:19798-19808.
2. Asher G, Lotem J, Kama R, Sachs L, and Shaul Y (2002) NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 99:3099-3104.
3. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, et al. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10:64-71.
4. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, et al. (2003) Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1. Cancer Res 63:929-935.
5. Benson AM, Hunkeler MJ, and Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216-5220.
6. Bianchet MA, Faig M, and Amzel LM (2004) Structure and mechanism of NAD[P]H: quinone acceptor oxidoreductases (NQO). Methods Enzymol 382:144-174.
7. Caplan AI and Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
8. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899-909.
9. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, and Sackstein R (2001) CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153:1277-1286.
10. Ernster L (1967) DT-diaphorase. Methods Enzymol 10:309-317.
11. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, and Wagner DD (1996) Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84:563-574.
12. Kerzic PJ, Pyatt DW, Zheng JH, Gross SA, Le A, and Irons RD (2003) Inhibition of NF-kappaB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-alpha-induced apoptosis. Toxicology 187:127-137.
13. Kopp HG, Avecilla ST, Hooper AT, and Rafii S (2005) The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 20: 349-356.
14. Kordula T, Bugno M, Rydel RE, and Travis J (2000) Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes. J Neurosci 20:7510-7516.
15. Krajinovic M, Sinnett H, Richer C, Labuda D, and Sinnett D (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97:230-236. (Pubitemid 34019960)
16. Lan Q, Zhang L, Shen M, Smith MT, Li G, Vermeulen R, Rappaport SM, Forrest MS, Hayes RB, Linet M, et al. (2005) Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res 65:9574-9581.
17. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, and Smith MT (1999) Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapyrelated myeloid leukemia. Blood 94:803-807.
18. Li Z and Li L (2006) Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 31:589-595.
19. Long DJ 2nd, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, and Jaiswal AK (2002) Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res 62:3030-3036. (Pubitemid 34602390)
20. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Lv L, Kerzic P, Lin G, Schnatter AR, Bao L, Yang Y, Zou H, Fu H, Ye X, Gross SA, et al. (2007) The TNF-alpha 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene. Leuk Res 31:1479-1485.
22. Mantovani A, Bussolino F, and Dejana E (1992) Cytokine regulation of endothelial cell function. FASEB J 6:2591-2599.
23. Min W and Pober JS (1997) TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/ CDC42-JNK-c-Jun/ATF2 pathways. J Immunol 159:3508-3518. (Pubitemid 127482110)
24. Moran JL, Siegel D, and Ross D (1999) A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 96:8150-8155.
25. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, et al. (2000) Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6:4091-4095.
26. Naylor MA, Swann E, Everett SA, Jaffar M, Nolan J, Robertson N, Lockyer SD, Patel KB, Dennis MF, Stratford MR, et al. (1998) Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7- dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro. J Med Chem 41:2720-2731.
27. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, and Collins T (1997) Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 272:2753-2761.
28. Ross D (2000) The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J Toxicol Environ Health A 61:357-372.
29. Ross D and Siegel D (2004) NAD(P)H:quinone oxidoreductase 1 (NQO1, DTdiaphorase), functions and pharmacogenetics. Methods Enzymol 382:115-144.
30. Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, et al. (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57:2839-2842.
31. Schweitzer KM, Vicart P, Delouis C, Paulin D, Dräger AM, Langenhuijsen MM, and Weksler BB (1997) Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 76:25-36.
32. Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, and Ross D (2004) NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65:1238-1247.
33. Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, and Felix CA (2002) Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 100:4590-4593.
34. Son DS, Roby KF, and Terranova PF (2004) Tumor necrosis factor-alpha induces serum amyloid A3 in mouse granulosa cells. Endocrinology 145:2245-2252.
35. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, and Ross D (1997) Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 75:69-75. (Pubitemid 27007275)
36. Travis LB, Li CY, Zhang ZN, Li DG, Yin SN, Chow WH, Li GL, Dosemeci M, Blot W, Fraumeni JF Jr, Hayes RB, and Linet MS (1994) Hematopoietic malignancies and related disorders among benzene-exposed workers in China. Leuk Lymphoma 14:91-102.
37. Vermeulen M, Le Pesteur F, Gagnerault MC, Mary JY, Sainteny F, and Lepault F (1998) Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92:894-900. (Pubitemid 28355472)
38. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, and Greaves MF (1999) A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 59:4095-4099.
39. Winski SL, Faig M, Bianchet MA, Siegel D, Swann E, Fung K, Duncan MW, Moody CJ, Amzel LM, and Ross D (2001) Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches. Biochemistry 40:15135-15142.
40. Wright DE, Wagers AJ, Gulati AP, Johnson FL, and Weissman IL (2001) Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-1936.
41. Zhou H, Dehn D, Kepa JK, Siegel D, and Ross D (2007) Proc Am Assoc Cancer Res 48:5371.
42. Zhou H, Kepa JK, Siegel D, Miura S, Hiraki Y, and Ross D (2009) Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells. Mol Pharmacol 76:579-587.